Atlas Trials

Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects

Clinical trial NCT02331433 · COMPLETED

Trial details

NCT number
NCT02331433
Sponsor
CoMentis
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-12-01
Primary completion
2015-11-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.